Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

574
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
574
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.0K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.0K
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

567
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
567
Cancer Survival Analysis01:21

Cancer Survival Analysis

806
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
806

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fifty years of structural equation modeling: A history of generalization, unification, and diffusion.

Social science research·2022
Same author

Late Cardiac Tamponade 4 Years After Total Artificial Heart Implantation.

The Annals of thoracic surgery·2020
Same author

The Crowd, the Cloud and Improving the Future of Medical Device Innovation.

Forum for health economics & policy·2019
Same author

Frequencies of Private Mentions and Sharing of Mammography and Breast Cancer Terms on Facebook: A Pilot Study.

Journal of medical Internet research·2017
Same author

Electronic medical record-based multicondition models to predict the risk of 30 day readmission or death among adult medicine patients: validation and comparison to existing models.

BMC medical informatics and decision making·2015
Same author

Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments.

Journal of comparative effectiveness research·2015

Related Experiment Video

Updated: Mar 5, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

919

The Challenges in Predicting ECMO Survival, and a Path Forward.

Marco Huesch1, Christopher Brehm

  • 1From the *Milton S. Hershey Medical Center, Hershey, Pennsylvania; †Department of Radiology, and Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, Pennsylvania; and ‡Pennsylvania State University College of Medicine, Heart and Vascular Institute, Hershey, Pennsylvania.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|March 25, 2017
PubMed
Summary

Extracorporeal membrane oxygenation (ECMO) offers life support but requires better mortality risk analytics. Current research is insufficient for diverse extracorporeal life support (ECLS) uses, necessitating improved methods for accurate predictions.

More Related Videos

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

13.1K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.4K

Related Experiment Videos

Last Updated: Mar 5, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

919
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

13.1K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.4K

Area of Science:

  • Cardiovascular Medicine
  • Pulmonary Medicine
  • Critical Care Medicine

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a vital but complex therapy for severe cardiac or pulmonary failure.
  • Increased ECMO utilization over 15 years highlights the need for robust mortality risk analytics.
  • Existing risk analytics inadequately address the diverse indications and configurations of extracorporeal life support (ECLS).

Purpose of the Study:

  • To address the insufficiency in current ECMO/ECLS risk analytics research.
  • To propose a framework for developing specific and robust mortality risk analytics.
  • To meet the growing demand for accurate risk prediction from clinicians, patients, and administrators.

Main Methods:

  • Review of current literature on ECMO/ECLS risk prediction models.
  • Analysis of existing data gaps concerning diverse ECLS configurations and indications.
  • Development of a conceptual framework for future risk analytics research.

Main Results:

  • Current mortality risk analytics for ECMO/ECLS are insufficient and lack specificity.
  • Significant heterogeneity in ECMO/ECLS applications is not adequately captured by existing models.
  • A clear need exists for tailored risk analytics based on specific patient populations and ECLS strategies.

Conclusions:

  • Enhanced, specific mortality risk analytics are crucial for optimizing ECMO/ECLS patient care.
  • Further research is required to develop and validate advanced risk prediction tools for ECLS.
  • A standardized approach to risk analytics will improve clinical decision-making and resource allocation.